HerResolve provides an accurate “detected/not detected” diagnosis of endometriosis, allowing women to safely avoid exploratory surgery when the disease is not present, and enables doctors to diagnose earlier and begin active pharmaceutical or surgical management.

HerResolve demonstrates superior performance in validation studies and is intended to decrease medically unnecessary exploratory procedures and guide personalized treatment.

Presently, HerResolve is available through doctors participating in the early access program and shortly will be available to doctors nationwide to order for their patients. Contact us today to learn more.